Modulation by low sodium intake of glomerular response to cicletanine and atrial natriuretic factor

British Journal of Pharmacology

Volumn 121, Issue 4, 1997, Pages 635-642

  Kalinowski, Leszek ^a   Szczepanska Konkel, Miroslawa ^a   Jankowski, Maciej ^a   Angielski, Stefan ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

ANF; Cicletanine; Cyclic GMP; Cyclic GMP phosphodiesterase; Glomerular effects; Kidney; Low sodium diet

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CICLETANINE; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; ENZYME INHIBITOR; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY FLOW; CONTROLLED STUDY; DIURESIS; GLOMERULUS; GLOMERULUS FILTRATION RATE; LEISURE; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM RESTRICTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DIURETICS; GLOMERULAR FILTRATION RATE; MALE; PYRIDINES; RATS; RATS, WISTAR; SODIUM, DIETARY;

EID: 0030986708     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701160     Document Type: Article

References (44)

1. ANDREWS, P.M. (1981). Investigations of cytoplasmic contractile and cytoskeletal elements in the kidney glomerulus. Kidney Int., 20, 549-562.
2. ANGIELSKI, S., KUCHTA, G., REDLAK, M. & SZCZEPANSKAKONKEL, M. (1990). Attenuated glomerular responses to atrial natriuretic factor in low-sodium rats is prevented by theophylline. Biochem. Biophys. Res. Commun., 170, 596-602.
3. ARRIBA, L.J., BARRIO, V., OLIVERA, A., RODRIGUEZ-PUYOL, D. & LOPEZ-NOVOA, J.M. (1988). Atrial natriuretic peptide inhibits angiotensin II-induced contraction of isolated glomeruli and cultured glomerular mesangial cells of rats: the role of calcium. J. Lab. Clin. Med., 111, 466-474.
4. AUGUET, M., DELAFLOTTE, S., HELLEGOUARCH, A., GUILLON, J.M., BARANES, J., PIROTZKY, E., CLOSTRE, F. & BRAQUET, P. (1988). In vitro cardiovascular antihistamine properties of cicletanine in comparison with diphenhydramine. Drugs Exp. Clin. Res., 14, 1988.
5. BIANCHI, C., GUTKOWSKA, J., THIBAULT, G., GARCIA, R., GENEST, J. & CANTIN, M. (1986). Distinct localization of atrial natriuretic factor and angiotensin II binding sites in the glomerulus. Am. J. Physiol., 251, F594-F602.
6. BIZON, D., KALINOWSKI, L. & ANGIELSKI, S. (1992). Adenosine deaminase restores the ability of atrial natriuretic peptide to induce glomerular hyperfiltration in low-sodium rats. Eur. J. Clin. Chem. Clin. Biochem., 30, 647-649.
7. BRATTON, A.C. & MARSHALL, E.K. (1939). A new coupling component for sulfanilamide determination. J. Biol. Chem., 128, 537-540.
8. BRENNER, B.M., BALLERMANN, B.J., GUNNING, M.E. & ZEIDEL, M.L. (1990). Diverse biological actions of atrial natriuretic peptide. Physiol. Rev., 70, 665-700.
9. BUKOSKI, R.D., BO, J., XUE, H. & BIAN, K. (1993). Antiproliferative and endothelium-dependent vasodilator properties of 1,3-dihydro-3-p-chlorophenyl-7-hydroxy-6-methyl-furo-(3,4c) pyridine hydrochloride (Cicletanine). J. Pharmacol. Exp. Ther., 265, 30-35.
10. CALDER, J., SCHACHTER, M. & SEVER, P.S. (1992a). Mechanisms of action of cicletanine in human and guinea pig resistance arteries. J. Cardiovasc. Pharmacol., 19, 387-393.
11. CALDER, J., SCHACHTER, M. & SEVER, P.S. (1992b). Interaction between cicletanine and eicosanoid system in human subcutaneous resistance arteries. J. Pharm. Pharmacol., 44, 574-578.
12. CHABRIER, P.E., GUINOT, P., TARRADE, T., AUGUET, M., CABANIE, M., CLOSTRE, F., ETIENNE, A., ESANU, A. & GRAQUET, P. (1988). Cicletanine. Cardiovasc. Drug. Rev., 6, 166-179.
13. CUENO, R.C., ESPINER, E.A., NICHOLLS, M.G., YANDLE, T.G., JOYCE, S.L. & GILCHRIST, N.L. (1986). Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake. J. Clin. Endocrinol. Metab., 63, 946-953.
14. DAMASE, M.C., GIROLAMI, J.P., BASCANDS, J.L., TRAN, M.A., MOATTI, J.P., PECHER, C., BERTHET, P., TARRADE, T. & MONTASTRUC, J.L. (1991). Effects of cicletanine on vasoactive systems in conscious sinoaortic-denervaled dogs. Fundam. Clin. Pharmacol., 5, 719-732.
15. 1 in spontaneously hypertensive rats. Arch. Mal. Coeur, Vaiss., 82, 37-40.
16. DEITMER, P., GOLENHOFEN, K. & NOACK, T. (1992). Comparison of the relaxing effects of cicletanine and chromacalim on vascular smooth muscle. J. Cardiovasc. Pharmacol., 20, 35-42.
17. DORIAN, B., DARET, D., BRAQUET, P. & LARRUE, J. (1988). Cicletanine and eicosanoids in cultured vascular smooth muscle cells. Drugs Exp. Clin. Res., 14, 117-122.
18. DWORKIN, I.D., ICHIKAWA, I. & BRENNER, B.M. (1983). Hormonal modulation of glomerular function. Am. J. Physiol., 244, F95-F104.
19. EMOND, C., BOMPART, G., RAKOTOARIVONY, J., BASCANDS, J.L., PECHER, C., ADAM, A., TARRADE, T., BERTHET, P. & GIROLAMI, J.P. (1992). Protective effect of cicletanine on hypertension-induced decreases in the renal kallikrein-kinin and prostaglandin systems in stroke-prone spontaneously hypertensive rats. J. Cardiovasc. Pharmacol., 20, 601-608.
20. ++-activated K channels and contraction of cultured smooth muscle cells of porcine coronary artery. J. Pharmacol. Exp. Ther., 256, 371-377.
21. FUJIWARA, Y., KITAMURA, E., UEDA, N., FUKUNAGA, M., ORITA, Y. & KAMADA, T. (1989). Mechanism of action of angiotensm II on isolated rat glomeruli. Kidney Int., 36, 985-991.
22. GARAY, R.P., ROSATI, C., FANOUS, K., ALLARD, M., MORIN, E., LAMIABLE, D. & VISTELLE, R. (1995). Evidence for (+)-cicletanine sulfate as an active natriuretic metabolite of cicletanine in the rat. Eur. J. Pharmacol., 274, 175-180.
23. GREVEN, J., RAHN, A. & BRÄNDLE, E. (1995) Effects of cicletanine on kidney function. 2. Role of renal prostaglandins and kinins, and muscarinic receptors. J. Pharmacol. Exp. Ther., 273, 1197-1202.
24. HEYROWSKY, A. (1956). A new method for determination of inulin in plasma and urine. Clin. Chim. Acta. 1, 470-476.
25. HORNYCH, H., BEAUFILS, M. & RICHET, G. (1972). The effect of exogenous angiotensin on superficial and deep glomeruli in the rat kidney. Kidney Int., 2, 336-343.
26. HORNYCH, H., BOISSON, J. & GASCHARD, J.C. (1989). Reduction of kidney prostaglandin synthesis in patients with essential hypertension. Stimulating effect of cicletanine. Arch. Mal. Coer. Vaiss., 82, 85-90.
27. JIN, H.K., YANG, R.H., ESUNGE, P., CHEN, Y.F., DURAND, J. & OPARIL, S. (1991). Antihypertensive effect of cicletanine is exaggerated in NaCl-sensitive hypertension. Am. J. Med. Sci., 301, 383-389.
28. KALINOWSKI, L., SZCZEPANSKA-KONKEL, M., PAWEŁCZYK, T., BIZON, D. & ANGIELSKI, S. (1995). Inhibition of cGMP-phosphodiesterase restores the glomerular effects of atrial natriuretic factor in low sodium diet rats. Renal. Physiol. Biochem., 18, 254-266.
29. KOLTAI, M., ESANU, A. & BRAQUET, P. (1990). Relaxation of vascular smooth muscle by cicletanine importance of potassium channels and prostacyclin. In Klinische Pharmakologie, Clinical Pharmacology, Vol. 7, Importance of Prostacyclin and Potassium Channels for the Regulation of Vascular Tone. ed. Frölich, J.C. & Förstermann, U. pp. 106-136. Munich: W. Zuckschwerdt Verlag.
30. LOWRY, O.H., ROSENBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 256-275.
31. MALHERBE, E., BARANES, J., LE HEGARAT, M., CLOSTRE, F. & BRAQUET, P. (1986). Difference between some antihypertensive drugs on blood pressure and cardiac effects in young SHR-SP. J. Pharmacol., 17, 193-196.
32. NOACK, T. & DEITMER, P. (1993). Effects of cicletanine on whole-cell currents of single smooth muscle cells from the guinea-pig portal vein. Br. J. Pharmacol., 109, 164-170.
33. PLANTE, G.E., PICHETTE, M. & REGOLLI, D. (1990). Cicletanine-induced phosphaturia and the kinin system. In Diuretics III, ed. Puschett J.B. & Greenberg, A. pp. 133-136. New York: Elsevier.
34. ROHMEISS, P., CHUNG, O., ROHMEISS, S. & UNGER, T. (1990). Cicletanine: A new antihypertensive drug with a muscarinergic action. In Advances in Hypertension Research: Prostacyclin and Cardiovascular Regulation, ed. Rosenthal J. pp. 17-25. New York: Zuckschwerdt Verlag.
35. SAVIN, V.J. & TERREROS, D.A. (1981). Filtration in single isolated mammalian glomeruli. Kidney Int., 20, 188-197.
36. SCHOR, N., ICHIKAWA, I. & BRENNER, B.M. (1981). Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int., 20, 442-451.
37. SECHI, L.A., GRADY, E.F., GRIFFIN, C.A., KALINYAK, J.E. & SCHAMBELAN, M. (1992). Distribution of angiotensin II receptor subtypes in rat and human kidney. Am. J. Physiol., 262, F236-F240.
38. SHENKER, Y. (1988). Atrial natriuretic hormone effect on renal function and aldosterone secretion in sodium depletion. Am. J. Physiol., 255, R867-R873.
39. m cyclic GMP phosphodiesterases and potentiation of guanylate cyclase activators by cicletanine. J. Cardiovasc. Pharmacol., 16, 501-505.
40. ++-regulated protein kinases and relationship to vasorelaxation by cicletanine. J. Pharmacol. Exp. Ther., 1, 382-391.
41. 2 and cyclic guanosine 3′,5′-monophosphate. Effects of altered sodium intake. Hypertension, 23, 1068-1070.
42. + channels are responsible for angiotensin II hypersensitive contraction and atrial natriuretic factor refractoriness of glomeruli in low-sodium rats. Biochem. Biophys. Res. Commun., 181, 871-876.
43. TSUNODA, K., ABE, K., OMATA, K., HAGINO, T., MINAMI, N., MUNAKATA, M., YOSHIDA, K., SAKUMA, H., MISAWA, S. & ARIMA, S. (1993). Effects of cicletanine on the urinary excretion of prostanoids and kallikrein, and on renal function in man. Cardiovasc. Drugs Ther., 7, 253-256.
44. UEHARA, Y., NUMABE, A., HIRAWA, N., KAWABATA, Y., IWAI, J., ONO, H., MATSUOKA, H., TAKABATAKE, Y., YAGI, S. & SUGIMOTO, T. (1991). Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats. J. Hypertens., 9, 719-728.